It is well known for helping reduce appetite, improve blood sugar control, and support steady weight loss
Most patients experience their strongest side effects during weeks one through three, then notice significant improvement by week four
Clinical Applications in Inflammatory Conditions Inflammatory Bowel Disease (IBD) Preclinical studies have demonstrated BPC-157's efficacy in experimental models of IBD, including both ulcerative colitis and Crohn's disease
Diabetes Care 40 , 614624 (2017)
Saito Y, Shichiri M, Hamajima T, Ishida N, Mita Y, Nakao S, et al
Obes Surg 29(1):314 AziziKia H et al (2024) Periprocedural changes of serum biomarkers in predicting complications following bariatric surgery for obesity: systematic review and meta-analysis